Viewing StudyNCT00416923



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00416923
Status: COMPLETED
Last Update Posted: 2015-02-16
First Post: 2006-12-27

Brief Title: Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Conditions & Keywords Data

Conditions:
Name
Brain and Central Nervous System Tumors
Lymphoma
Keywords:
Name View
splenic marginal zone lymphoma View
recurrent adult Burkitt lymphoma View
recurrent adult diffuse large cell lymphoma View
recurrent adult diffuse mixed cell lymphoma View
recurrent adult immunoblastic large cell lymphoma View
recurrent adult lymphoblastic lymphoma View
recurrent grade 1 follicular lymphoma View
recurrent grade 2 follicular lymphoma View
recurrent grade 3 follicular lymphoma View
recurrent adult diffuse small cleaved cell lymphoma View
recurrent mantle cell lymphoma View
recurrent marginal zone lymphoma View
recurrent small lymphocytic lymphoma View
stage IV adult Burkitt lymphoma View
stage IV adult diffuse large cell lymphoma View
stage IV adult diffuse mixed cell lymphoma View
stage IV adult diffuse small cleaved cell lymphoma View
stage IV adult immunoblastic large cell lymphoma View
stage IV adult lymphoblastic lymphoma View
stage IV grade 1 follicular lymphoma View
stage IV grade 2 follicular lymphoma View
stage IV grade 3 follicular lymphoma View
stage IV mantle cell lymphoma View
stage IV marginal zone lymphoma View
stage IV small lymphocytic lymphoma View
primary central nervous system non-Hodgkin lymphoma View
leptomeningeal metastases View
intraocular lymphoma View
AIDS-related primary CNS lymphoma View
Waldenström macroglobulinemia View
extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
nodal marginal zone B-cell lymphoma View